Engineers transport a 350-volt battery pack to be installed in a Fedex Corp. truck. Express General Motors Co. (GM) at the VIA Motors Inc. facility. In Orem, Utah, US on Monday, February 17, 2014.
George Fry | Bloomberg | Getty Images
Here are the stocks making the headlines after the bell.
FedEx – Shares of the shipping company rose more than 3% after FedEx issued upbeat guidance for the full fiscal year, forecasting a rise in adjusted earnings. FedEx reported mixed results for its recently completed fiscal fourth quarter, with $6.87 in adjusted earnings per share on $24.39 billion in revenue. Analysts polled by Refinitiv expected $6.86 in earnings per share on $24.56 billion in revenue.
Sarepta treatments –Biopharmaceuticals stock is down more than 5% in extended trading after the US Food and Drug Administration imposed a clinical suspension of the Sarepta treatment for Duchenne muscular dystrophy. Sarepta said there was a “serious adverse event” in one of the studies of this treatment.
Smith & Wesson Brands – Shares of the firearms maker fell about 2% after Smith & Wesson’s fourth-quarter fiscal report showed a year-over-year decline in revenue and gross margin. The company, which has a market capitalization of about $650 million, raised its quarterly dividend to 10 cents per share from 8 cents.
“Web maven. Infuriatingly humble beer geek. Bacon fanatic. Typical creator. Music expert.”
More Stories
FCC reinstates net neutrality in blow to ISPs
Boeing's financial problems continue, while families of crash victims urge the United States to sue the company
Asian Stocks Set to Decline as Meta Slows in Big Tech Companies: Markets Wrap